# Bioequivalence Study of Nefopam Hydrochloride 30mg Tablets vs Acupan® 30mg Tablets in Healthy Subjects

> **NCT03311022** · PHASE1 · COMPLETED · sponsor: **Galen Limited** · enrollment: 29 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Nefopam Hydrochloride 30mg Tablets
- **DRUG:** Acupan® 30mg Tablets

## Key facts

- **NCT ID:** NCT03311022
- **Lead sponsor:** Galen Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-06
- **Primary completion:** 2015-12-21
- **Final completion:** 2015-12-21
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2017-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03311022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03311022, "Bioequivalence Study of Nefopam Hydrochloride 30mg Tablets vs Acupan® 30mg Tablets in Healthy Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03311022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*